© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Progyny, Inc. (PGNY) stock surged +2.15%, trading at $29.45 on NASDAQ, up from the previous close of $28.83. The stock opened at $29.25, fluctuating between $29.08 and $30.10 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 01, 2026 | 29.25 | 30.10 | 29.08 | 29.45 | 1.5M |
| Jun 30, 2026 | 28.68 | 29.21 | 28.62 | 28.83 | 1.26M |
| Jun 29, 2026 | 28.46 | 28.99 | 28.25 | 28.86 | 1.28M |
| Jun 26, 2026 | 27.25 | 28.57 | 27.25 | 28.51 | 1.6M |
| Jun 25, 2026 | 26.89 | 27.38 | 26.85 | 27.38 | 789.37K |
| Jun 24, 2026 | 26.80 | 27.19 | 26.79 | 26.89 | 888.62K |
| Jun 23, 2026 | 26.50 | 26.78 | 26.33 | 26.63 | 1.28M |
| Jun 22, 2026 | 26.43 | 26.93 | 26.25 | 26.28 | 1.93M |
| Jun 18, 2026 | 26.62 | 26.66 | 25.95 | 26.08 | 3.07M |
| Jun 17, 2026 | 26.57 | 26.84 | 26.15 | 26.31 | 1.18M |
| Jun 16, 2026 | 26.91 | 27.36 | 26.49 | 26.60 | 1.76M |
| Jun 15, 2026 | 26.65 | 27.17 | 25.93 | 26.91 | 1.37M |
| Jun 12, 2026 | 25.65 | 26.74 | 25.19 | 26.63 | 1.31M |
| Jun 11, 2026 | 25.95 | 26.09 | 25.50 | 25.65 | 1.18M |
| Jun 10, 2026 | 25.96 | 26.13 | 25.50 | 25.89 | 1.12M |
| Jun 09, 2026 | 25.84 | 26.24 | 25.70 | 25.83 | 1.56M |
| Jun 08, 2026 | 25.96 | 26.42 | 25.69 | 25.92 | 1.61M |
| Jun 05, 2026 | 25.47 | 26.09 | 25.19 | 25.86 | 1.21M |
| Jun 04, 2026 | 25.08 | 25.99 | 25.08 | 25.48 | 953.84K |
| Jun 03, 2026 | 25.02 | 25.14 | 24.70 | 24.99 | 1.34M |
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
| Employees | 675 |
| Beta | 1.04 |
| Sales or Revenue | $1.09B |
| 5Y Sales Change% | 7.865% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |